When birth control pills moved from prescription-only to over-the-counter status, reproductive health advocates celebrated a major victory for access. But a University of Mississippi study has now revealed a troubling gap: young women aged 16 to 24 often don't understand how these pills actually work or what side effects they might experience—knowledge that becomes critical when they're choosing and managing medication on their own.
The research, led by graduate student Ivy Leong and pharmacy professor Erin Holmes at Ole Miss, surveyed young women across the nation to assess their understanding of birth control pills. The timing is significant. Over-the-counter availability was meant to remove barriers to access, yet self-directed medication requires something prescriptions often provided: informed decision-making. "Accessing birth control pills without a prescription is a significant and positive advancement in women's reproductive health," Holmes explained. "With that in mind, this research sought to understand young women's knowledge about birth control so that health care professionals, including pharmacists, can better understand how to educate and support this population."
The study asked participants nine questions covering pill use, efficacy, indication, mechanism of action, risks, and side effects. The results were sobering: the average knowledge score was just 4.08 out of 9—moderate at best. Roughly 45 percent of participants lived in the South, with 20 percent each from the Midwest and West, giving the findings a genuinely national scope. Young women most consistently struggled with three critical areas: understanding the medication's side effects, explaining how the pill prevents pregnancy, and knowing what to do if they missed a dose. Even among those specifically interested in using over-the-counter birth control, the knowledge score barely budged to 4.11 out of 9, with side effects and mechanism of action remaining weak spots.
This isn't a failure of young women—it's a gap in how information reaches them. Leong and Holmes see the study as a roadmap for improvement. "Understanding birth control pill knowledge among young populations provides insights into areas that can be strengthened, such as how to manage side effects and how the pill prevents pregnancy," Leong said. The researchers point squarely at manufacturers and pharmacists as key players. When pharmaceutical companies create educational materials, when pharmacists counsel patients, when decision-aid websites and health apps are designed, these knowledge gaps should guide the conversation. Tools like bedside.org already exist to help women without easy access to in-person care, though such online resources lack the personalization that a real conversation with a health care provider can offer.
The stakes matter because knowledge shapes outcomes. A young woman who understands potential side effects is better equipped to tolerate them or recognize when to seek help. One who grasps the pill's mechanism—how it prevents ovulation, thickens cervical mucus, thins the uterine lining—is more likely to use it consistently and correctly. Those who know what to do after a missed dose are less likely to experience contraceptive failure. As Leong noted, "Knowledge about birth control pills can ensure appropriate and safe use, as self-medication selection and management become important in the over-the-counter setting." The path forward isn't rolling back access—it's matching that access with real education, delivered by pharmacists, manufacturers, and digital tools working in concert to ensure that young women don't just have pills at their fingertips, but understanding in their hands.